Skip to main content
Clinical Trials/NCT00392275
NCT00392275CompletedPhase 4

Penetrance of Third Generation Fluoroquinolones in Eyes With Functioning Filtering Blebs

Indiana University School of Medicine6 sites in 1 country48 target enrollmentStarted: November 2002Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
48
Locations
6
Primary Endpoint
Aqueous levels of antibiotics

Study Overview

Brief Summary

Based on previous results with eyes without filtering blebs, the aqueous concentrations of ofloxacin and levofloxacin will exceed the concentration of ciprofloxacin after either topical or topical plus oral administration.

Detailed Description

The purpose of this study is to assay human aqueous for concentrations of ofloxacin, ciprofloxacin and levofloxacin after topical or combined topical and oral administration in eyes with filtering blebs.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All patients with functioning filtering blebs will be evaluated prospectively for inclusion

Exclusion Criteria

  • Any subject who is already scheduled to have cataract surgery performed will qualify for participation with the exception of the following exclusion criteria:
  • Ongoing ocular inflammatory disease
  • Bleb leakage - determined by Seidel test
  • Suspected infection
  • Known contraindications to use of any of these study medications.
  • Pregnancy

Outcomes

Primary Outcomes

Aqueous levels of antibiotics

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (6)

Loading locations...

Similar Trials

Penetrance of Third Generation... | Clinical Trial